Test Price
2,800 AEDโ Home Collection Available
CRX Gene Cone-Rod Dystrophy Type 2 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
This definitive, DHA-aligned genetic test delivers 99.9% diagnostic sensitivity for cone-rod dystrophy type 2, utilizing ISO 9001:2015โcertified cold-chain home collection and VIP mobile phlebotomy. The test is processed under strict quality assurance with next-generation sequencing (NGS) covering the entire CRX gene. Post-test telephonic genetic counselling is included, and direct insurance pre-authorization verification is available via WhatsApp.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM โ 11 PM)
- Clinical Guidance: Telephonic Post-Test Genetic Counselling for result interpretation
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731
Test Overview & Methodology
This next-generation sequencing (NGS) test identifies pathogenic DNA variants in the entire CRX gene to confirm type 2 cone-rod dystrophy diagnosis. The analysis covers all coding exons and adjacent intronic regions using ISO-validated bioinformatics pipelines. Concurrent CNV (copy number variant) analysis is performed to detect deletions/duplications not visible by Sanger sequencing.
| Feature | Our CRX NGS Test | Closest Alternative |
|---|---|---|
| Precision | Full CRX gene sequencing (99.9% sensitivity) | Sanger sequencing of selected exons (98.5%) |
| Methodology | Next Generation Sequencing (NGS) with CNV analysis | Targeted mutation panel |
| Speed | 3โ4 Weeks | 6โ8 Weeks |
Physician Insight & Safety Protocols
โAs a Consultant Medical Genetics in the UAE, I emphasize that the CRX gene test is a powerful diagnostic aid for cone-rod dystrophy type 2. However, results must always be interpreted alongside a comprehensive ophthalmological examination and thorough genetic counselling. I encourage patients and referring physicians to contact our team for any followโup questions after testing.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication & Clinical Guidance
Do not discontinue or alter any prescribed medication without consulting your treating physician. This genetic test provides diagnostic information; it does not replace immediate ophthalmic care for acute symptoms.
Safety Exclusion Criteria & Emergency Red Flags
- Patient must be clinically stable for home phlebotomy; active ophthalmic emergency (acute vision loss, severe ocular pain) requires immediate hospital evaluation.
- Known bleeding disorders or anticoagulant therapy must be disclosed prior to sample collection; INR >3.0 excludes home draw.
- Testing is not performed on minors without consent of a legal guardian, in accordance with Federal Law No. 2 of 2019 and DHA regulatory guidelines.
- If you experience sudden worsening of vision, floaters, or flashes, seek emergency ophthalmic care immediately โ do not wait for genetic results.
Patient FAQ & Clinical Guidance
1. What exactly does the CRX gene test detect, and how long does it take?
Snippet: This NGS test identifies pathogenic DNA variants in the entire CRX gene to confirm type 2 cone-rod dystrophy diagnosis within 3โ4 weeks.
The analysis covers all coding exons and adjacent intronic regions, using ISO-validated bioinformatics pipelines. Fast-track options may be available in urgent cases.
2. Who are the appropriate specialists to interpret this test in the UAE?
Snippet: A DHA-licensed ophthalmologist, a clinical geneticist, and a certified genetic counsellor form the optimal integrated care team for this result.
We coordinate directly with your existing physician or connect you with our vetted network of retinal dystrophy specialists across Dubai and Abu Dhabi.
3. Is this test covered by insurance, and what are the sample requirements?
Snippet: Most UAE insurers cover this 2800 AED genetic test with pre-authorization; samples accepted are whole blood, extracted DNA, or a single drop on an FTA card.
We provide a complimentary pre-authorisation check via WhatsApp. A genetic counselling session to draw a pedigree chart is mandatory before testing, as per DHA pre-test guidelines.
UAE Regulatory & Data Privacy Adherence
This test and all associated data handling fully comply with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) โ safeguarding patient genetic information.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields โ governing secure electronic health records.
- Federal Decree-Law No. 4 of 2016 on Medical Liability โ ensuring clinical safety and informed consent.
- DHA Healthcare Facility Standards and ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | CRX Gene Cone-Rod Dystrophy Type 2 Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV Analysis |
| ICD-10-CM Code | H35.52, H35.50 |
| LOINC Code | 85724-9 |
| DHA Facility License & Laboratory Address | DNA Labs UAE, DHA License 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians